All examined xenograft tumors revealed very small overlap between CD44+/CD24+ and ALDHhigh or ALDHlow cell populations, representing 0.015% and 0.11% respectively, of all viable, human tumor cells. The gene discussed is CD24; the disease is neoplasm.